Literature DB >> 10415864

Pancreatic cancer: development of a unifying etiologic concept.

A B Lowenfels1, P Maisonneuve.   

Abstract

Our knowledge of the etiology of all forms of cancer including pancreatic cancer has improved dramatically in the second half of this century. The current model describes a gradual change from a normal pancreatic cell to a fully malignant cell requiring several stages with gradual and progressive alterations appearing at the genetic and the tissue level. Although there are many germ line diseases that are associated with pancreatic cancer it is probable that inherited diseases account for only about 10% of the total burden of pancreatic cancer. Avoidance of smoking and dietary modification are the current best strategies for reducing the risk of this tumor. In addition, newer molecular techniques and imaging procedures should provide clinicians with the ability to detect pancreatic cancer at an early, potentially curable stage.

Entities:  

Mesh:

Year:  1999        PMID: 10415864     DOI: 10.1111/j.1749-6632.1999.tb09523.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

1.  Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage.

Authors:  Miquel Porta; Xavier Fabregat; Núria Malats; Luisa Guarner; Alfredo Carrato; Ana de Miguel; Laura Ruiz; Manuel Jariod; Sergi Costafreda; Susana Coll; Juan Alguacil; Josep M Corominas; Ricard Solà; Antonio Salas; Francisco X Real
Journal:  Clin Transl Oncol       Date:  2005-06       Impact factor: 3.405

2.  ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis.

Authors:  Harvey A Risch; Lingeng Lu; Jing Wang; Wei Zhang; Quanxing Ni; Yu-Tang Gao; Herbert Yu
Journal:  Am J Epidemiol       Date:  2013-05-06       Impact factor: 4.897

3.  Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis.

Authors:  Harvey A Risch; Herbert Yu; Lingeng Lu; Mark S Kidd
Journal:  Am J Epidemiol       Date:  2015-06-06       Impact factor: 4.897

4.  Impact of Sixteen Established Pancreatic Cancer Susceptibility Loci in American Jews.

Authors:  Samantha A Streicher; Alison P Klein; Sara H Olson; Laufey T Amundadottir; Andrew T DeWan; Hongyu Zhao; Harvey A Risch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-07-28       Impact factor: 4.254

5.  Unusually high rate of young-onset pancreatic cancer in the East Nile Delta region of Egypt.

Authors:  Amr S Soliman; Nabih El-Ghawalby; Farouk Ezzat; Melissa L Bondy; Ahmed Soultan; Mohamed Abdel-Wahab; Omar Fathy; Gamal Ebidi; Nadia Bassiouni; Ahmed El-Ghawalbi; Bernard Levin; James L Abbruzzese
Journal:  Int J Gastrointest Cancer       Date:  2002

6.  PCCR: Pancreatic Cancer Collaborative Registry.

Authors:  Simon Sherman; Oleg Shats; Marsha A Ketcham; Michelle A Anderson; David C Whitcomb; Henry T Lynch; Paola Ghiorzo; Wendy S Rubinstein; Aaron R Sasson; William E Grizzle; Gleb Haynatzki; Jianmin Feng; Alexander Sherman; Leo Kinarsky; Randall E Brand
Journal:  Cancer Inform       Date:  2011-03-23

7.  Serum cadmium levels in pancreatic cancer patients from the East Nile Delta region of Egypt.

Authors:  Alison M Kriegel; Amr S Soliman; Qing Zhang; Nabih El-Ghawalby; Farouk Ezzat; Ahmed Soultan; Mohamed Abdel-Wahab; Omar Fathy; Gamal Ebidi; Nadia Bassiouni; Stanley R Hamilton; James L Abbruzzese; Michelle R Lacey; Diane A Blake
Journal:  Environ Health Perspect       Date:  2006-01       Impact factor: 9.031

8.  Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea: a case-control study.

Authors:  Sang Myung Woo; Jungnam Joo; Woo Jin Lee; Sang-Jae Park; Sung-Sik Han; Tae Hyun Kim; Young Hwan Koh; Hyun Bum Kim; Eun Kyung Hong
Journal:  J Korean Med Sci       Date:  2013-01-29       Impact factor: 2.153

9.  Exocrine pancreatic pathology in female Harlan Sprague-Dawley rats after chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like compounds.

Authors:  Abraham Nyska; Micheal P Jokinen; Amy E Brix; Donald M Sells; Michael E Wyde; Denise Orzech; Joseph K Haseman; Gordon Flake; Nigel J Walker
Journal:  Environ Health Perspect       Date:  2004-06       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.